Sun Pharmaceutical Industries Limited: Keratosis, Actinic trials

The registry lists 16 Keratosis, Actinic studies with Sun Pharmaceutical Industries Limited as lead sponsor. 3 are open to participants now and 8 have results posted.

Phase 1 4Phase 2 7Phase 3 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the FaceRecruitingNCT07729579Phase 1
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper ExtremitiesRecruitingNCT07144852Phase 3
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and ScalpRecruitingNCT07144345Phase 3
• Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on FaceCompletedNCT02632110Phase 2Results posted
• Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)CompletedNCT02628236Phase 2Results posted
• Maximal Use Systemic Exposure (MUSE) Study of Levulan KerastickCompletedNCT02281136Phase 2Results posted
• Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic TherapyCompletedNCT02239679Phase 2Results posted
• Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper ExtremitiesCompletedNCT02137785Phase 3Results posted
• Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)CompletedNCT01475955Phase 2Results posted
• Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)CompletedNCT01458587Phase 2Results posted
• Bioequivalence Study of Two Imiquimod Cream 5%CompletedNCT00828568Phase 1Results posted
• Phase 3 Study of Levulan With New Blue Light for AK on the Face or ScalpWithdrawnNCT03024060Phase 3
• Twelve Month Follow-Up of CP0108CompletedNCT02209012
• Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.CompletedNCT01788007Phase 1
• A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic KeratosisCompletedNCT01742663Phase 1
• ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant RecipientsTerminatedNCT00865878Phase 2